Allan V. Espinosa
-
- Thyroid Cancer Diagnosis and Treatment 3
- Oncology top 10%
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 2
-
- RNA modifications and cancer 2
- Signaling Pathways in Disease 2
- Wnt/β-catenin signaling in development and cancer 2
- Cancer-related gene regulation 2
- Reproductive Medicine top 10%
-
- Neuropeptides and Animal Physiology 2
- Co-authors
- Matthew D. RingelMotoyasu SajiLeonardo M. PorchiaVasily VaskoHerbert AuerО. С. ЛарінSandya LiyanarachchiGary L. Francis
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Clinical & Experimental Metastasis (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Allan V. Espinosa
12 papers receiving 715 citations
Peers
Comparison fields: 5 of 63
- Endocrinology, Diabetes and Metabolism 219
- Cancer Research 134
- Oncology 241
- Molecular Biology 502
- Reproductive Medicine 55
Countries citing papers authored by Allan V. Espinosa
This map shows the geographic impact of Allan V. Espinosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan V. Espinosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan V. Espinosa more than expected).
Fields of papers citing papers by Allan V. Espinosa
This network shows the impact of papers produced by Allan V. Espinosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan V. Espinosa. The network helps show where Allan V. Espinosa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allan V. Espinosa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 3 | |
| 2 | 2015 | 76 | |
| 3 | 2013 | 53 | |
| 4 | 2013 | 1 | |
| 5 | 2011 | 56 | |
| 6 | 2009 | 24 | |
| 7 | 2008 | 21 | |
| 8 | 2007 | 270 | |
| 9 | 2007 | 66 | |
| 10 | OSU03012, a novel PDK1 inhibitor, decreases thyroid cancer proliferation and migration via multiple downstream pathways. | 2006 | 1 |
| 11 | 2006 | 82 | |
| 12 | 2005 | 68 |
About Allan V. Espinosa
Allan V. Espinosa is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology, having authored 12 papers that have together received 721 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), RNA modifications and cancer (2 papers), Signaling Pathways in Disease (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cancer-related gene regulation (2 papers), Cancer-related Molecular Pathways (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (219 citations), Cancer Research (134 citations) and Oncology (241 citations). Allan V. Espinosa has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Matthew D. Ringel, Motoyasu Saji, Leonardo M. Porchia, Vasily Vasko, Herbert Auer, О. С. Ларін, Sandya Liyanarachchi, Gary L. Francis, Albert de la Chapelle and Huiling He. Their work appears in journals such as Proceedings of the National Academy of Sciences, Clinical & Experimental Metastasis, Clinical Cancer Research, British Journal of Cancer and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.